ArticleBMC gastroenterology2025
The effects of family-based Helicobacter pylori infection control and management strategies in Southwest China households: a two-year retrospective cohort study.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThere is a lack of data on the effects of family-based Helicobacter pylori (H. pylori) infection control and management (FBCM) strategies in Southwest China. This study aimed to evaluate the two-year outcomes of these strategies in affected households.
methodsIndividuals who participated in a two-year H. pylori survey in Chongqing (China) were included in the study. Households where all H. pylori-infected members underwent eradication treatment were classified as group A, while those that did not follow whole family eradication therapy were designated as group B. The eradication rate, incidence of new infections, and changes in hygiene and living habits, were compared between the two groups.
resultsThis study included 472 cases from 171 families, including 296 in group A and 176 in group B. The eradication rate in group A was significantly higher than that in group B (89.39% vs. 70.45%, p = 0.003). The compliance (87.88% vs. 84.09%, p = 0.519) and timely reexamination rates (46.97% vs. 31.82%, p = 0.063) were similar between the two groups. Among H. pylori-infected cases, the endoscopy uptake rate in group A was significantly higher than that in group B (30.30% vs. 13.98%, p = 0.004). Group A exhibited significant hygiene improvements after 2 years, including reduced raw water drinking (5.74% vs. 2.36%, p = 0.037), decreased shared cup usage (27.70% vs. 9.46%, p < 0.001), and increased individual dining (6.08% vs. 16.22%, p < 0.001). Group B showed decreased shared plate usage (26.14% vs. 5.11%, p < 0.001) and increased plate disinfection rates (25.00% vs. 44.89%, p < 0.001).
conclusionThe FBCM strategy significantly improved H. pylori eradication rates and promoted healthier hygiene behaviors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.